Found: 25
Select item for more details and to access through your institution.
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 583, doi. 10.3350/cmh.2022.0294
- By:
- Publication type:
- Article
The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 706, doi. 10.3350/cmh.2021.0390
- By:
- Publication type:
- Article
Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 725, doi. 10.3350/cmh.2022.0015
- By:
- Publication type:
- Article
Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 739, doi. 10.3350/cmh.2022.0060
- By:
- Publication type:
- Article
Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 754, doi. 10.3350/cmh.2021.0394
- By:
- Publication type:
- Article
Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 773, doi. 10.3350/cmh.2021.0383
- By:
- Publication type:
- Article
Nonalcoholic fatty liver disease versus metabolicassociated fatty liver disease: Prevalence, outcomes and implications of a change in name.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 790, doi. 10.3350/cmh.2022.0070
- By:
- Publication type:
- Article
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 802, doi. 10.3350/cmh.2022.0249
- By:
- Publication type:
- Article
Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 806, doi. 10.3350/cmh.2022.0208
- By:
- Publication type:
- Article
Surveillance for hepatocellular carcinoma: It is time to move forward.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 810, doi. 10.3350/cmh.2022.0257
- By:
- Publication type:
- Article
The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 814, doi. 10.3350/cmh.2022.0099
- By:
- Publication type:
- Article
Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 827, doi. 10.3350/cmh.2022.0068
- By:
- Publication type:
- Article
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 841, doi. 10.3350/cmh.2022.0239
- By:
- Publication type:
- Article
Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 851, doi. 10.3350/cmh.2022.0037
- By:
- Publication type:
- Article
Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 864, doi. 10.3350/cmh.2022.0136
- By:
- Publication type:
- Article
Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 876, doi. 10.3350/cmh.2022.0231
- By:
- Publication type:
- Article
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 890, doi. 10.3350/cmh.2022.0087
- By:
- Publication type:
- Article
Decreased vitamin D-binding protein level portends poor outcome in acute-on-chronic liver failure caused by hepatitis B virus.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 912, doi. 10.3350/cmh.2022.0121
- By:
- Publication type:
- Article
Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 926, doi. 10.3350/cmh.2022.0233
- By:
- Publication type:
- Article
Forms of cholangitis to be considered after SARS-CoV-2 infection.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 929, doi. 10.3350/cmh.2022.0260
- By:
- Publication type:
- Article
Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 931, doi. 10.3350/cmh.2022.0259
- By:
- Publication type:
- Article
Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 933, doi. 10.3350/cmh.2022.0267
- By:
- Publication type:
- Article
Personalized medicine in nonalcoholic fatty liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 935, doi. 10.3350/cmh.2022.0175
- By:
- Publication type:
- Article
Erratum to ‘History and future of hepatitis B virus control in South Korea’ [Clin Mol Hepatol 2021;27:620-622].
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 939, doi. 10.3350/cmh.2021.0277.e1
- By:
- Publication type:
- Article
Erratum to ‘KASL clinical practice guidelines for management of chronic hepatitis B’ [Clin Mol Hepatol 2022;28:276-331].
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 940, doi. 10.3350/cmh.2022.0084.e1
- Publication type:
- Article